Healthcare -
Biotechnology - NASDAQ - US
$ 7.58
-2.57 %
$ 162 M
Market Cap
-1.53
P/E
ENTA - OTHER LONG-TERM ASSETS
Other Long-term Assets ENTA - Enanta Pharmaceuticals, Inc.
3.45 M
LAST VALUE
-13.94%
2 YEAR CAGR
37.61%
5 YEAR CAGR
22.99%
10 YEAR CAGR